Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids-Reference-Cited by-同舟云学术

Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids

Published:2017-07-05 Issue:4 Volume:14 Page:
ISSN:1567-2018
Container-title:Current Drug Delivery
language:en
Short-container-title:CDD

Author:

Yazdani Mona¹,Jalali Seyed Amir²,Badiee Ali³,Shariat Sheida⁴,Mansourian Mercedeh³,Arabi Leila³,Abbasi Azam³,Saberi Zahra³,Jaafari Mahmoud Reza⁵

Affiliation:

1. Department of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran

2. Department of Immunology, Faculty of Medicine, ShahidBeheshti University of Medical Sciences, Tehran, Iran

3. Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

4. School of Pharmacy, ShahidBeheshti University of Medical Science, Tehran, Iran

5. Biotechnology Research Center, Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice;Acta Pharmacologica Sinica;2024-07-29

2. Liposomal celecoxib combined with dendritic cell therapy enhances antitumor efficacy in melanoma;Journal of Controlled Release;2023-02

3. Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection;Biomedicine & Pharmacotherapy;2023-02

4. Smart Lipid-Based Nanosystems for Therapeutic Immune Induction against Cancers: Perspectives and Outlooks;Pharmaceutics;2021-12-23

5. Current Prospects in Peptide-Based Subunit Nanovaccines;Vaccine Design;2021-12-17